v3.26.1
Equity Transactions (Tables)
9 Months Ended 12 Months Ended
Mar. 31, 2026
Jun. 30, 2025
Equity [Abstract]    
Schedule of summarizes the activity relating to the Company’s stock options
                    
   Options   Weighted-Average Exercise Price   Weighted Remaining Average Contractual Term   Aggregate Intrinsic Value 
Outstanding at June 30, 2025   84,872   $286.20    6.2   $- 
Options Granted   2,706,550   $1.31    7.6   $243,590 
Options Expired   (6,059)  $1,091.98    0.0   $- 
Outstanding at March 31, 2026   2,785,363   $7.62    7.6   $243,590 
Exercisable at March 31, 2026   1,606,299   $10.51    7.4   $139,018 
                    
   Options   Weighted-Average Exercise Price   Weighted Remaining Average Contractual Term   Aggregate Intrinsic Value 
Outstanding at June 30, 2023   39,529   $710.00    6.3   $1,067,966 
Granted   15,525    117.00    9.8    - 
Options Expired   (64)   460.90    -    - 
Options Canceled   (3,182)   571.90    -    - 
Outstanding at June 30, 2024   51,808    541.10    6.1    - 
Options Granted   49,031    24.01    7.1    - 
Options Expired   (7,725)   553.23    -    - 
Options Canceled   (8,242)   (78.75)   -    - 
Outstanding at June 30, 2025   84,872   $286.20    6.2   $- 
Exercisable at June 30, 2025   49,920   $387.85    5.4   $- 
Schedule of assumptions used
          
   March 31, 2026   March 31, 2025 
Expected life of options (in years)   5    4 
Expected volatility   89.31%   93.44%
Risk free interest rate   3.69%   4.34%
Dividend Yield   0%   0%
          
   June 30, 2025   June 30, 2024 
Expected life of options (in years)   4    6 
Expected volatility   93.44%   86.28%
Risk free interest rate   4.34%   4.40%
Dividend Yield   0%   0%
Schedule of vesting of restricted stock units
          
   Number of Shares   Weighted Average Grant Date Fair Value Per Share 
Unvested at June 30, 2025   7,213   $116.41 
Granted   1,500    1.58 
Vested   (7,614)   83.67 
Unvested at March 31, 2026   1,099   $187.02 
          
   Number of Shares   Weighted Average Grant Date Fair Value Per Share 
Unvested at June 30, 2023   5,965   $524.00 
Issued   10,407    91.60 
Vested   (12,240)   169.40 
Canceled   (103)   612.00 
Unvested at June 30, 2024   4,029   $445.90 
Issued   17,190    25.60 
Vested   (11,314)   107.60 
Canceled   (2,693)   70.75 
Unvested at June 30, 2025   7,212   $116.41 
Summary of warrants activity
                    
   Number of Shares   Weighted Average Exercise Price   Weighted Average Remaining Life (Years)   Aggregate Intrinsic Value 
Outstanding and exercisable at June 30, 2025   960,098   $35.02    4.1   $- 
Granted   6,967,300    2.50    5.0    - 
Canceled   (25,001)   150.00    -    - 
Expired   (360)   1,250.00    -    - 
Outstanding and exercisable at March 31, 2026   7,902,037   $5.82    4.2   $- 
                    
   Number of Shares   Weighted Average Exercise Price   Weighted Average Remaining Life (Years)   Aggregate Intrinsic Value 
Outstanding and exercisable at June 30, 2023   77,703   $206.00    4.0   $18,318,954.00 
Granted   175,500    131.40    5.0    - 
Exercised   (60,000)   100.00    -    - 
Outstanding and exercisable at June 30, 2024   193,203   $140.30    4.0   $- 
Granted   1,018,210    16.54    4.8    - 
Exercised   (250,297)   15.31    -    - 
Expired   (1,018)   218.81    -    - 
Outstanding and exercisable at June 30, 2025   960,098   $35.02    4.1   $- 
Schedule of expiration of the warrants outstanding
     
   Number of Warrants 
     
Expiring June 30,     
2027   3,610 
2028   72,728 
2029   90,508 
2030   767,891 
2031   6,967,300 
Total outstanding warrants   7,902,037 
     
   Number of Warrants 
     
Expiring June 30,   - 
2026   360 
2027   3,610 
2028   72,728 
2029   115,509 
2030   767,891 
Total outstanding warrants   960,098